medline.ch Gastroenterologie Pankreas Neoplasie

	Reverse-Bevel (ProCore) EUS-Guided Fine-Needle Biopsy for Solid Pancreatic Mass Lesions: a GRADE-Assessed Systematic Review and Meta-Analysis of Prospective Randomized Trials. J Gastrointest Cancer Mirza W, Badshah MB, Gastroenterologist I, Hadhoud AM, Moeen-Ud-Din MB, Imtiaz A. PMID: 42406286 [PubMed - indexed for MEDLINE]
	The forgotten burden: nutrition impact symptoms in colorectal cancer survivorship. Curr Opin Support Palliat Care Furness K, Solheim-Hustad K, Kaasa S. PMID: 42405505 [PubMed - as supplied by publisher]
	Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer. Front Cell Infect Microbiol Wang Y, Wu J. PMID: 42404769 [PubMed - indexed for MEDLINE]
	Preoperative nutritional status, frailty, and postoperative delirium in patients undergoing pancreatic cancer surgery: a prospective observational study. Front Nutr Xia N, Ding L, Shi N, Song Y, Pan KC. PMID: 42404151 [PubMed]
	Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. Pain Van Diepen AE, Graus MUJE, Augustinus S, Gehrels AM, Vissers PAJ, van Gansewinkel EHE, Besselink MG, van Laarhoven HWM, Bouwense SAW, Wilmink JW, Cirkel GA, Kooreman NG, Alvarez Jimenez R, van Zundert J, Homs MYV, van Kuijk SMJ, de Vos-Geelen J, Dutch Pancreatic Cancer Group. PMID: 42402901 [PubMed - as supplied by publisher]
	Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study. J Hepatol Oh DY, Ikeda M, Macarulla T, He AR, Park JO, Kitano M, Giordano G, Kim KP, Wirth T, Tai D, Bouattour M, Pressiani T, Dayyani F, Lamarca A, Emeribe U, Radke S, Sun P, Baur B, Vogel A. PMID: 42402265 [PubMed - as supplied by publisher]
	A primary care clinic on the frontline of early cancer detection: a retrospective observational study. BMC Prim Care Yago Y, Hojo M, Shibuya T, Tsujimoto T, Nagahara A. PMID: 42401800 [PubMed - as supplied by publisher]
	Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a retrospective study. BMC Gastroenterol Ueda T, Miyagawa K, Shibata M, Mori Y, Oe S, Kajitani K, Uchihara D, Shinohara N, Ogino N, Kumei S, Honma Y, Watanabe T, Harada M. PMID: 42399778 [PubMed - as supplied by publisher]
	Anatomically constrained deep learning for clinical-grade volumetric pancreatic cancer segmentation: development, validation, and architectural benchmarking. NPJ Precis Oncol Mukherjee S, Bhinder KK, Zarrintan A, Antony A, Ammirabile A, Jadoon A, Dey S, Talukdar BJ, Yamaguchi T, Graham RP, Chari ST, Goenka AH. PMID: 42399351 [PubMed - as supplied by publisher]
	Semiannual surveillance facilitates detection of surgically treatable intraductal papillary mucinous neoplasm-derived and concomitant carcinoma: a multicenter prospective observational study. Pancreatology Ohashi Y, Maruta A, Koizumi T, Iwata S, Uemura S, Tezuka R, Iwasa Y, Okuno M, Iwata K, Mukai T, Ichikawa H, Mita N, Yoshida K, Iwashita T, Shimizu M. PMID: 42399187 [PubMed - as supplied by publisher]
	Patients with hepatitis B virus-related hepatocellular carcinoma underlying cirrhosis have higher microvascular invasion and poorer prognosis after liver resection: A multicenter study. Hepatobiliary Pancreat Dis Int Cao Y, Zhang TC, Li ZQ, Yu ZT, Hu MG, Ni QQ, Xu S, Chen X, Tan G, Wang X, Xia NX, Zhao WC, Zhang F, Lu YM, Tang YF, Hu YL, Jiang T, Lin C, Cheng SQ, Zhang XP, Liu R. PMID: 42399131 [PubMed - as supplied by publisher]
	Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. Gut Xiang YJ, Liu ZH, Feng JK, Qin YY, Yu HM, Cheng YQ, Chen G, Wu JY, Zeng YY, Tang YF, Rao JH, Zhang FM, Yang SY, Wang GR, Ye LS, Lang R, Lin JH, Zheng YT, Mao YF, Zhou HK, Yan ML, Liang C, Ren SS, Wang K, Gong L, Xu S, Xu YF, Ni QQ, Wang K, Fan RF, Hu YL, Jiang T, Lin C, Gao QL, Wang ZQ, Lu YM, Zou WB, Wang X, Feng C, Wang ZC, Liu PJ, Wei WJ, Zhang F, Wu W, Lu HF, Huang JY, Liang X, Li JJ, Shan YF, Zhang XP, Cheng SQ, Chinese Association of Liver Cancer and Chinese Medical Doctor Association. PMID: 42399086 [PubMed - as supplied by publisher]
	The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets. Int Immunopharmacol Maher F, Samadi A, Sajjadi SF, Heydari S, Gross J, Azimi G. PMID: 42398175 [PubMed - as supplied by publisher]
	Pancreatic Adenocarcinoma Presented as Paraneoplastic Dermatomyositis Complicated with Rhabdomyolysis: Case Report and Review. Am J Case Rep Alsheyyab J, Al-Mahasneh HA, Al-Khalaileh SY, Hasan HA, Al-Refu K. PMID: 42397795 [PubMed - indexed for MEDLINE]
	Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study. medRxiv Rousseau B, Hilmi M, Falcoz A, Vernerey D, Toullec C, Lecomte T, Lambert A, Tournigand C, Guerin-Meyer V, Louvet C, Trouilloud I, Rinaldi Y, Coriat R, Dauba J, Neuzillet C, André T, Bachet JB, Cros J, de la Fouchardiere C, Garcia-Larnicol ML, de Gramont A, Hammel P. PMID: 42396273 [PubMed]
	Emerging role of proteomics in advancing diagnosis, prognosis, and treatment of liver cancer. Liver Res Xu Y, Li J, Luo X, Xiang Z, Yang Z, Wei X, Xu X, Chen J. PMID: 42395637 [PubMed]
	The National Clinical Database Risk Calculator and the 5-Item Modified Frailty Index Predict the Development of Postoperative Delirium After Surgery for Hepatocellular Carcinoma. Ann Gastroenterol Surg Hosoda K, Shimizu A, Kubota K, Notake T, Sakai H, Yoshikawa K, Ikehara T, Hayashi H, Yasukawa K, Soejima Y. PMID: 42395150 [PubMed]
	Differential Prognostic Impact of Prior Cholecystectomy Between Proximal and Distal Colorectal Cancer: A 12-Year Retrospective Cohort Study of 3487 Consecutive Patients. Ann Gastroenterol Surg Tsunematsu M, Haruki K, Yanamoto K, Takehana T, Ishizaki S, Yanagaki M, Shirai Y, Furukawa K, Onda S, Ikegami T. PMID: 42395139 [PubMed]
	Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery. Ann Gastroenterol Surg Kosaka H, Kinoshita M, Yasuda S, Kakizaki S, Sugimoto R, Sakata J, Yamai K, Hatanaka T, Yamamoto Y, Sato T, Ishikawa T, Morikawa T, Hanaoka J, Mori H, Toyoda H, Sanuki T, Yokoi M, Shibata H, Fukuda K, Kawata K, Amaya K, Ito T, Hidaka M, Naganuma A, Sugimachi K, Toshiyama S, Yamasaki M, Kaibori M. PMID: 42395119 [PubMed]
	Surgical Outcomes and Recurrence Management in Borderline Resectable Hepatocellular Carcinoma: Implications for Multidisciplinary Strategies. Ann Gastroenterol Surg Haruki K, Furukawa K, Akaoka M, Yamahata Y, Onda S, Shirai Y, Tsunematsu M, Taniai T, Matsumoto M, Ikegami T. PMID: 42395111 [PubMed]

Artikel 1 - 20 / 60735

Seite 1 von 3037

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung